Orient Pharma Co., Ltd.
|Orient Pharma Co., Ltd. Patent applications|
|Patent application number||Title||Published|
|20150174009||MULTI-LAYER CAPSULE AND MANUFACTURE METHOD THEREOF - The present invention provides multi-layer capsules and manufacture methods thereof Different materials are added in sequence into a capsule to form a multi-layer capsule without diffusion and/or interaction between layers.||06-25-2015|
|20130310420||STABLE FORMULATIONS OF PITAVASTATIN - Disclosed is a pharmaceutical composition comprising pitavastatin, or its salt or ester and MgO, of which the aqueous solution or dispersion has pH of from 10 to 10.8. The composition has good time-dependent stability and has no change in its outward appearance even after having been stored long.||11-21-2013|
|20120316213||COMBINATION OF ALPHA-2 RECEPTOR AGONIST (CLONIDIN) AND ANTI-MUSCARINIC AGENT (OXYBUTYNIN) FOR THE TREATMENT OF SIALORRHOEA - An alpha2 adrenoreceptor agonist eg. clonidine, brimonidine, monoxidine, lofexidine is useful for the treatment of siaiorrhoea, administered by the paraungual, sublingual or buccal route. The patient to be treated is also given an anti-muscarinic agent eg. oxybutynin, glycopyrrolate, ipratropium.||12-13-2012|
|20090297591||Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds - The present invention is directed to compositions and methods for the transdermal delivery of a pharmaceutically active compound. In some embodiments, the addition of inert pharmaceutical ingredients in place of a portion of adhesive in a transdermal patch formulation increases the rate of skin permeation of a pharmaceutical compound.||12-03-2009|
Patent applications by Orient Pharma Co., Ltd.